Capital Market Strategies LLC Has $611,000 Position in The Procter & Gamble Company (NYSE:PG)

Capital Market Strategies LLC grew its holdings in The Procter & Gamble Company (NYSE:PG) by 6.5% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 3,644 shares of the company’s stock after buying an additional 224 shares during the quarter. Capital Market Strategies LLC’s holdings in Procter & Gamble were worth $611,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Itau Unibanco Holding S.A. acquired a new position in shares of Procter & Gamble during the second quarter worth approximately $28,000. Fairway Wealth LLC acquired a new position in Procter & Gamble during the 2nd quarter worth $29,000. RPg Family Wealth Advisory LLC bought a new position in Procter & Gamble in the 3rd quarter valued at $33,000. Quest Partners LLC acquired a new stake in shares of Procter & Gamble in the 2nd quarter valued at $36,000. Finally, Fairfield Financial Advisors LTD bought a new stake in shares of Procter & Gamble during the second quarter worth $44,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Stock Down 2.2 %

NYSE PG traded down $3.71 on Monday, reaching $161.42. The company had a trading volume of 3,100,842 shares, compared to its average volume of 4,497,018. The company’s fifty day moving average is $170.21 and its 200-day moving average is $169.85. The Procter & Gamble Company has a 1-year low of $146.28 and a 1-year high of $180.43. The firm has a market capitalization of $380.15 billion, a price-to-earnings ratio of 27.83, a price-to-earnings-growth ratio of 3.70 and a beta of 0.45. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. The business had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. Procter & Gamble’s quarterly revenue was down .6% on a year-over-year basis. During the same period last year, the company earned $1.83 earnings per share. On average, research analysts forecast that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were given a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.49%. The ex-dividend date was Friday, October 18th. Procter & Gamble’s dividend payout ratio is presently 69.31%.

Analyst Ratings Changes

A number of analysts recently commented on the company. DA Davidson reiterated a “buy” rating and issued a $209.00 price objective on shares of Procter & Gamble in a research report on Friday, December 27th. Royal Bank of Canada reissued a “sector perform” rating and set a $164.00 price target on shares of Procter & Gamble in a research note on Monday, October 21st. Piper Sandler began coverage on shares of Procter & Gamble in a report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 target price for the company. JPMorgan Chase & Co. increased their price target on Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research note on Thursday, September 19th. Finally, Wells Fargo & Company lifted their price objective on Procter & Gamble from $188.00 to $190.00 and gave the stock an “overweight” rating in a research note on Friday, November 22nd. Eight investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $180.45.

Insider Buying and Selling

In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the firm’s stock in a transaction that occurred on Thursday, October 24th. The stock was sold at an average price of $168.99, for a total value of $2,163,072.00. Following the completion of the transaction, the insider now directly owns 11,566 shares in the company, valued at $1,954,538.34. This trade represents a 52.53 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO R. Alexandra Keith sold 1,992 shares of the business’s stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $170.00, for a total value of $338,640.00. Following the transaction, the chief executive officer now directly owns 13,783 shares in the company, valued at $2,343,110. This trade represents a 12.63 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 75,439 shares of company stock worth $13,317,460. 0.18% of the stock is owned by insiders.

Procter & Gamble Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.